Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The latter is a pandemic that has the potential of developing into a severe illness manifesting as systemic inflammatory response syndrome, acute respiratory distress syndrome, multi-organ involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Popovic, Djordje S., Papanas, Nikolaos, Pantea Stoian, Anca, Rizvi, Ali A., Janez, Andrej, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546380/
https://www.ncbi.nlm.nih.gov/pubmed/34699021
http://dx.doi.org/10.1007/s13300-021-01170-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546380/
https://www.ncbi.nlm.nih.gov/pubmed/34699021
http://dx.doi.org/10.1007/s13300-021-01170-3

Ejemplares similares